IT1256925B - Use of timosine α 1 fragments and/or derivatives - Google Patents
Use of timosine α 1 fragments and/or derivativesInfo
- Publication number
- IT1256925B IT1256925B ITTO920683A ITTO920683A IT1256925B IT 1256925 B IT1256925 B IT 1256925B IT TO920683 A ITTO920683 A IT TO920683A IT TO920683 A ITTO920683 A IT TO920683A IT 1256925 B IT1256925 B IT 1256925B
- Authority
- IT
- Italy
- Prior art keywords
- timosine
- fragments
- derivatives
- antagonist
- depression
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000008105 immune reaction Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A fragment and/or derivative of α 1 timosine, which may be in the form of a pharmaceutically acceptable salt, is used as an antagonist in depression of the immunological reaction produced by antitumoural agents.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO920683A IT1256925B (en) | 1992-08-05 | 1992-08-05 | Use of timosine α 1 fragments and/or derivatives |
| ES9301758A ES2119581B1 (en) | 1992-08-05 | 1993-08-05 | USE OF FRAGMENTS OF THYMOSINE AND / OR ITS DERIVATIVES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO920683A IT1256925B (en) | 1992-08-05 | 1992-08-05 | Use of timosine α 1 fragments and/or derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITTO920683A0 ITTO920683A0 (en) | 1992-08-05 |
| ITTO920683A1 ITTO920683A1 (en) | 1994-02-05 |
| IT1256925B true IT1256925B (en) | 1995-12-27 |
Family
ID=11410676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITTO920683A IT1256925B (en) | 1992-08-05 | 1992-08-05 | Use of timosine α 1 fragments and/or derivatives |
Country Status (2)
| Country | Link |
|---|---|
| ES (1) | ES2119581B1 (en) |
| IT (1) | IT1256925B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2288118B1 (en) * | 2006-05-10 | 2008-11-01 | Bcn Peptides, S.A. | PROCEDURE FOR SYNTHESIZING LYMPHOSINS. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4426324A (en) * | 1979-09-28 | 1984-01-17 | Hoffmann-La Roche Inc. | Immunopotentiating peptides |
| EP0033384B1 (en) * | 1980-01-18 | 1984-02-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Medicaments containing fragments of thymosin-alpha-1 with immunostimulating activity, and thymosin-alpha-1 fragments |
| US4374197A (en) * | 1980-10-30 | 1983-02-15 | Hoffmann-La Rocche Inc. | Process for thymosin α1 |
| EP0056594B1 (en) * | 1981-01-14 | 1984-09-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Thymosin-alpha-1 fragments and pharmaceutical compositions with immunoregulating action containing them |
| DE3137231A1 (en) * | 1981-09-18 | 1983-04-14 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | BIS-THYMOSINE (ALPHA) (DOWN ARROW) 1 (DOWN ARROW) CONNECTIONS |
| US4442031A (en) * | 1981-10-15 | 1984-04-10 | Hoffmann-La Roche Inc. | Immunopotentiating peptides |
-
1992
- 1992-08-05 IT ITTO920683A patent/IT1256925B/en active IP Right Grant
-
1993
- 1993-08-05 ES ES9301758A patent/ES2119581B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2119581B1 (en) | 1999-04-01 |
| ITTO920683A0 (en) | 1992-08-05 |
| ES2119581A1 (en) | 1998-10-01 |
| ITTO920683A1 (en) | 1994-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY131298A (en) | 5-heteroyl indole derivatives | |
| HU9403323D0 (en) | 4-mercaptioacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors | |
| HU9301361D0 (en) | Method for producing 4-aryl-piperazines and 4-aryl-piperidines | |
| GB9514473D0 (en) | Chemical compounds | |
| PL316658A1 (en) | Novel application of serotonin antagonists | |
| MY114393A (en) | 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1, 3-propanediol derivatives | |
| IT8819077A0 (en) | PROCESS FOR THE PREPARATION OF 1,2 DIFLUOROETHANE AND 1,1,2TRIFLUOROETHANE. | |
| EP0597830A4 (en) | Use of polyamines as ionic-channel regulating agents. | |
| UA41355C2 (en) | Agent for treating neuro-aids | |
| BG102589A (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists | |
| TW362096B (en) | Novel piperidine derivatives and the process for preparing the same | |
| GR850309B (en) | ||
| FI941776A7 (en) | Method for the preparation of 1,2,4-thiadiazoles | |
| DE58902899D1 (en) | 2 ', 3'-DIDEOXYPURINNUCLEOSIDE / PURINNUCLEOSIDE-PHOSPHORYLASE INHIBITOR COMBINATION THERAPY AND COMPOSITIONS THEREFOR. | |
| HUT70218A (en) | Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines | |
| KR970000398B1 (en) | Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane | |
| ZA913071B (en) | Treatment | |
| FI891473A0 (en) | Process for the preparation of therapeutically useful 4-aryl-4-piperidinecarbinols | |
| PT79855B (en) | Process for the preparation of indolphenantridines | |
| IT1256925B (en) | Use of timosine α 1 fragments and/or derivatives | |
| GR3005736T3 (en) | ||
| TW326033B (en) | Cyanobenzenesulfenyl halide and process for preparation of 3-substituted benzisothiazole using the same | |
| UA29461C2 (en) | An agent for treatment of amyloidosis, a method for treatment of amyloidosis | |
| ZA891242B (en) | 24r-scymnol,and preparation and use thereof | |
| AU5088690A (en) | Keratoconjunctivitis cytotoxin and methods for its use and production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19950831 |